SCULPTRA

A sculpting agent that restores volume to correct the signs of facial fat loss.

Until now, there were no products that had been approved by the FDA to treat the signs of facial lipoatrophy in people with human immunodeficiency virus.  However, that is all changing with the introduction of SCULPTRA.  SCULPTRA is intended for restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus.

The effects of SCULPTRA are enduring.  In a clinical study, effects lasted for up to 2 years after the first treatment session in most patients.  The results from SCULPTRA are not immediate; SCULPTRA provides a gradual increase in skin thickness.  Your health care provider will see you again in a few weeks to decide if additional injections are needed.  Touch-up treatments may be needed to maintain the desired effects. 

Dr. Zuzukin has treated numerous patients since May of 2005 with 100% success rate and no side effects.  Accordingly to leading cosmetic dermatologists and cosmetic laser surgeons, Sculptra is considered as the best semi-permanent filler with the same popularity as Botox, treating millions of patients.